Hyeon-Seok Eom Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

12/2016

Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyeon-Seok Eom Research Topics

Disease

26	Multiple Myeloma 01/2024 - 07/2009
15	Neoplasms (Cancer) 01/2024 - 09/2006
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022 - 12/2008
8	Lymphoma (Lymphomas) 11/2023 - 09/2010
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 07/2008
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2023 - 12/2013
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 12/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 08/2015
3	Infections 10/2022 - 12/2016
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2022 - 01/2021
2	Febrile Neutropenia 10/2022 - 01/2022
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 01/2013
2	Disease Progression 01/2022 - 08/2021
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 02/2020
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 09/2014
2	Extranodal NK-T-Cell Lymphoma 12/2016 - 11/2014
2	Thrombocytopenia (Thrombopenia) 12/2013 - 07/2009
2	Fever (Fevers) 12/2013 - 04/2010
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023
1	Atrial Fibrillation 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Frailty 01/2021
1	Sepsis (Septicemia) 01/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 09/2017
1	Hemolysis 09/2017
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 09/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2017
1	Chromothripsis 09/2017
1	Hyperbilirubinemia 12/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2016

Drug/Important Bio-Agent (IBA)

13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2023 - 12/2008
13	Rituximab (Mabthera)FDA Link 01/2023 - 12/2008
12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 07/2009
11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2008
10	Bortezomib (Velcade)FDA Link 04/2023 - 07/2009
10	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 12/2008
8	Prednisone (Sone)FDA LinkGeneric 01/2023 - 12/2008
6	Melphalan (Alkeran)FDA LinkGeneric 08/2023 - 05/2010
6	Thalidomide (Thalomid)FDA Link 01/2022 - 05/2010
6	Lenalidomide (CC 5013)FDA Link 08/2021 - 01/2014
4	Busulfan (Busulfex)FDA Link 08/2023 - 01/2018
4	R-CHOP protocolIBA 01/2020 - 12/2008
3	Brentuximab VedotinIBA 11/2023 - 04/2020
3	AlbuminsIBA 02/2023 - 09/2017
3	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 05/2010
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2016
2	AntibodiesIBA 01/2024 - 06/2020
2	C-Reactive ProteinIBA 02/2023 - 01/2021
2	defibrotideIBA 01/2022 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 03/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 12/2016
2	Asparaginase (Elspar)FDA Link 12/2016 - 11/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2016 - 09/2016
2	AntigensIBA 01/2014 - 09/2006
2	CytokinesIBA 07/2008 - 01/2008
1	selinexorIBA 01/2024
1	tetrachloroisophthalonitrile (Bravo)IBA 11/2023
1	Drug CombinationsIBA 04/2023
1	AnthracyclinesIBA 01/2023
1	Bendamustine Hydrochloride FDA Link 12/2022
1	pegfilgrastim (Neulasta)FDA Link 10/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	zanubrutinibIBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	carfilzomibIBA 08/2021
1	ibrutinibIBA 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2020
1	Methylprednisolone FDA LinkGeneric 02/2020
1	Etoposide (VP 16)FDA LinkGeneric 02/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	pomalidomideIBA 01/2020
1	Proteasome InhibitorsIBA 01/2020
1	10-propargyl-10-deazaaminopterin FDA Link 12/2019
1	daratumumabIBA 01/2019
1	Histone Deacetylase InhibitorsIBA 10/2018
1	CKD-581IBA 10/2018
1	eculizumab FDA Link 09/2017
1	SteroidsIBA 01/2017
1	Alkylating AgentsIBA 01/2017
1	dimemorfan (AT 17)IBA 01/2017
1	CreatinineIBA 12/2016
1	Methotrexate (Mexate)FDA LinkGeneric 12/2016

Therapy/Procedure

14	Stem Cell Transplantation 08/2023 - 07/2009
14	Therapeutics 04/2023 - 12/2008
11	Drug Therapy (Chemotherapy) 01/2023 - 12/2008
5	Transplantation 01/2023 - 12/2006
5	Combination Drug Therapy (Combination Chemotherapy) 02/2020 - 04/2012
3	Hematopoietic Stem Cell Transplantation 01/2017 - 01/2013
2	Cell Transplantation 01/2022 - 08/2015
2	Immunotherapy 06/2020 - 09/2010
2	Aftercare (After-Treatment) 01/2020 - 09/2017
2	Induction Chemotherapy 01/2019 - 09/2017
2	Chemoradiotherapy 12/2016 - 11/2014
1	Blood Component Removal (Apheresis) 02/2021
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2019
1	Consolidation Chemotherapy 12/2016